CYP26A1 and CYP26C1 cooperatively regulate anterior–posterior patterning of the developing brain and the production of migratory cranial neural crest cells in the mouse  by Uehara, Masayuki et al.
02 (2007) 399–411
www.elsevier.com/locate/ydbioDevelopmental Biology 3CYP26A1 and CYP26C1 cooperatively regulate anterior–posterior
patterning of the developing brain and the production of
migratory cranial neural crest cells in the mouse
Masayuki Uehara a, Kenta Yashiro a,⁎, Satoru Mamiya a, Jinsuke Nishino a,1,
Pierre Chambon b, Pascal Dolle b, Yasuo Sakai a,2
a Developmental Genetics Group, Graduate School of Frontier Biosciences, Osaka University, and CREST, Japan Science and Technology Corporation (JST),
1-3 Yamada-oka, Suita, Osaka 565-0871, Japan
b Institut de Genetique et de Biologie Moleculaire et Cellulaire, CNRS/INSERM/ULP/College de France, BP10142, 67404 Illkirch Cedex,
C.U. de Strasbourg, France
Received for publication 22 June 2006; revised 25 September 2006; accepted 27 September 2006
Available online 30 September 2006Abstract
The appropriate regulation of retinoic acid signaling is indispensable for patterning of the vertebrate central nervous system along the
anteroposterior (A–P) axis. Although both CYP26A1 and CYP26C1, retinoic acid-degrading enzymes that are expressed at the anterior end of the
gastrulating mouse embryo, have been thought to play an important role in central nervous system patterning, the detailed mechanism of their
contribution has remained largely unknown. We have now analyzed CYP26A1 and CYP26C1 function by generating knockout mice. Loss of
CYP26C1 did not appear to affect embryonic development, suggesting that CYP26A1 and CYP26C1 are functionally redundant. In contrast, mice
lacking both CYP26A1 and CYP26C1 were found to manifest a pronounced anterior truncation of the brain associated with A–P patterning
defects that reflect expansion of posterior identity at the expense of anterior identity. Furthermore, Cyp26a1−/−Cyp26c1−/− mice fail to produce
migratory cranial neural crest cells in the forebrain and midbrain. These observations, together with a reevaluation of Cyp26a1 mutant mice,
suggest that the activity of CYP26A1 and CYP26C1 is required for correct A–P patterning and production of migratory cranial neural crest cells in
the developing mammalian brain.
© 2006 Published by Elsevier Inc.Keywords: Central nervous system; CYP26; Anteroposterior axis; Neural crest cells; Retinoic acidIntroduction
Retinoic acid (RA) plays important roles in vertebrate
embryonic development. Vitamin A deficiency (VAD) results in
a spectrum of developmental malformations known as VAD
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doi:10.1016/j.ydbio.2006.09.045intake of excess RA during pregnancy induces malformations
referred to as RA embryopathy (Lammer et al., 1985; Ross et
al., 2000). Animal models of VAD syndrome and RA
embryopathy suggest that RA is especially important for
development of the central nervous system (CNS). For instance,
treatment of chick or mouse embryos with an excess of RA
results in the loss of anterior structures including the forebrain,
most of the midbrain, and eyes, whereas the hindbrain and
spinal cord appear to expand in compensation (Maden, 2002).
Such effects have been observed in various vertebrates when
RA is administered at primitive streak stages (Avantaggiato et
al., 1996; Simeone et al., 1995). The absence of signaling by
RA receptors has also been shown to be required for rostral head
formation (Koide et al., 2001). On the other hand, an imposed
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results in sequential loss of the posterior hindbrain (Dupe and
Lumsden, 2001; Maden, 2002; Maden et al., 1996; Nieder-
reither et al., 2000). These observations thus indicate that RA
acts as a posteriorizing factor in patterning of the CNS along the
anterior–posterior (A–P) axis.
The intracellular level of active RA is determined by the
balance between its synthesis by retinaldehyde dehydrogenases
(RALDHs) and its degradation by CYP26 enzymes, the latter
of which constitute a group of P450 enzymes that metabolize
RA to inactive forms (Fujii et al., 1997; Ray et al., 1997; White
et al., 1996). CYP26 enzymes are thought to play a central role
in appropriate regulation of the RA signal as a posteriorizing
factor in CNS development (Abu-Abed et al., 2001; Sakai et al.,
2001; Sirbu et al., 2005). Mice and humans possess three
CYP26 genes: Cyp26a1, Cyp26b1, and Cyp26c1 (MacLean et
al., 2001; Nebert and Russell, 2002; Tahayato et al., 2003).Fig. 1. CNS abnormalities in Cyp26a1/c1−/− embryos. (A) Comparison of the pattern
wild-type (WT) mouse embryos as revealed by whole-mount in situ hybridization. Du
of the anterior region, whereas Cyp26a1 is also expressed in the neural plate and in th
through the corresponding embryos. Red arrowheads indicate Cyp26c1 expression in
Scanning electron micrographs of WT, Cyp26a1−/−, Cyp26c1−/−, Cyp26a1/c1−/−, an
(lower panels) views are shown for each embryo. Whereas Cyp26c1−/− embry
abnormalities, including an underdeveloped head and an open neural tube between th
shown). Two representative Cyp26a1−/− embryos are shown, one with an open neu
exposed to exogenous RA at both E7.5 and E8.5 developed CNS defects similar to tho
h, heart; mb, midbrain.During development of the early mouse embryo, RALDH2 is
expressed in the paraxial mesoderm, somites, and lateral plate
and serves as a source of RA (Niederreither et al., 1999).
Among the three Cyp26 genes, Cyp26a1 is initially expressed
in the head mesenchyme and neuroectoderm of mouse embryos
at embryonic day (E) 7.5, whereas Cyp26c1 is expressed only
in the head mesenchyme at the same time (see Fig. 1A). In
contrast, Cyp26b1 expression begins in the prospective
hindbrain at E8.0 (MacLean et al., 2001). Cyp26a1 mutant
mice manifest abnormal patterning of the hindbrain (Abu-Abed
et al., 2001; Sakai et al., 2001), although this phenotype is not
as severe as that expected from the pharmacological studies
with RA. Moreover, no obvious malformation was observed in
the CNS of Cyp26b1 mutant mice (Yashiro et al., 2004).
Although these studies have implicated CYP26 enzymes in
regulation of RA signaling during CNS patterning, the
expression of the other Cyp26 genes in the Cyb26a1 ors of Cyp26c1 and Cyp26a1 expression from the headfold to two-somite stages of
ring the period examined, Cyp26c1 and Cyp26a1 are expressed in the mesoderm
e extraembryonic endoderm. The planes of sectioning are indicated by the lines
r4. ee, embryonic ectoderm; em, embryonic mesoderm. Scale bars, 100 μm. (B)
d RA-treated [(RA(+)] WT embryos at E9.5. Lateral (upper panels) and dorsal
os appeared normal, Cyp26a1/c1−/− embryos manifested pronounced CNS
e forebrain and hindbrain; the neural tube in the trunk region was closed (data not
ral tube (left) and the other with no obvious CNS defects (right). WT embryos
se of Cyp26a1/c1−/− embryos. b1, first branchial arch; b2, second branchial arch;
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genes in this process. A recent study suggested that CYP26C1
performs a function distinct from that of CYP26A1 in CNS
patterning along the A–P axis (Sirbu et al., 2005), but the
detailed contributions of these enzymes have remained unclear,
mostly because of the lack of information on the effects of loss
of CYP26C1 function in mice.
We have now generated mice that lack either Cyp26c1 alone
or both Cyp26c1 and Cyp26a1 in order to provide insight into
the physiological functions of CYP26 enzymes in CNS
development. Our data suggest that a differential distribution
of RA generated by CYP26A1 and CYP26C1 patterns the
developing brain along the A–P axis and regulates organ
development from cranial neural crest cells (NCCs).
Materials and methods
Generation of Cyp26c1−/− mice
The targeting vector contained a loxP-FRT-neo-FRT cassette inserted into
intron 5 and a loxP cassette inserted into the 3′ untranslated region of Cyp26c1
(Supplementary Fig. 1). Six embryonic stem (ES) cell clones were confirmed to
have undergone homologous recombination. Two such clones (D10, K7) were
subjected to electroporation in the presence of an expression vector for Cre
recombinase, resulting in the generation of an allele that lacks exon 6 (Cyp26c1−).
Two resulting clones (D10′, K7′) were used to generate Cyp26c1−/− mice in the
present study.
Generation of Cyp26a1/c1−/− mice
The targeting vector contained a 19-kb region encompassing Cyp26c1 as
well as a loxP-FRT-neo-FRT cassette inserted at the XbaI site in the 5′ region of
the gene (Supplementary Fig. 2). The linearized targeting vector was introduced
into an ES cell line (R19–R93) in which one of the Cyp26a1 alleles had already
been deleted (Sakai et al., 2001). ES clones in which the neo cassette was
incorporated into the chromosome containing the Cyp26a1− allele were
obtained. Two such ES clones (C5, G15) were subjected to electroporation in
the presence of a Cre expression vector, resulting in the generation of a
chromosome lacking both Cyp26a1 and Cyp26c1 (Cyp26a1/c1−). Two resulting
clones (C5′, G15′) were used to generate Cyp26a1/c1+/− mice (B6/129 mixed
background).
RA treatment
RA treatment was performed as previously described (Yashiro et al., 2004)
with minor modifications. Pregnant ICR females were thus administered all-
trans-RA (8 mg kg−1, Sigma) in sesame oil (Sigma) by oral gavage. Control
females received sesame oil only.
Histological analysis
In situ hybridization was performed with whole-mount preparations as
previously described (Sakai et al., 2001). The RA signal was detected in
embryos as previously described (Sakai et al., 2001) after crossing Cyp26a1/
c1+/− mice harboring the RARE-hsplacZ transgene (Rossant et al., 1991) with
Cyp26a1/c1+/− mice. The resulting embryos were subjected to genotyping and
staining with 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-gal,
Wako) or 6-chloro-3-indolyl-β-D-galactopyranoside (Rose-gal, Slater and
Frith).
Antibodies
Immunohistochemical analysis was performed with primary antibodies
specific for E-cadherin (uvomorulin) (1:90 dilution, Sigma), N-cadherin (1:100dilution, Zymed), mature caspase-3 (1:200 dilution, Cell Signaling Technology),
or phosphorylated histone H3 (Upstate Biotechnology). Immune complexes
were detected with Alexa568- or Alexa488-conjugated secondary antibodies to
rabbit or mouse immunoglobulin G (1:400 dilution, Molecular Probes) or with a
peroxidase-based Vectastain kit (Vector). Neurofilament staining with a
monoclonal antibody (2H3; Developmental Studies Hybridoma Bank, Iowa
University) was performed for whole-mount detection of cranial nerves as
previously described (Sakai et al., 2001).
Analysis of the fates of cranial NCCs
Microinjection of DiI (1,1-dioctadecyl-3,3,3′,3′-tetramethylindocarbocya-
nine perchlorate, Molecular Probes) was performed as previously described
(Inoue et al., 2000). Mouse embryos that developed to the zero- to two-somite
stage were selected for DiI labeling. To label premigratory NCCs, we focally
injected DiI into the presumptive midbrain and rhombomere 4 (r4) regions. The
embryos were then cultured for 24 h as previously described (Nonaka et al.,
2002) before fixation with 4% paraformaldehyde in phosphate-buffered saline
and examination with a Leica MZ FL III stereomicroscope.Results
Cyp26c1−/− mice exhibit normal CNS development
First, to examine the role of Cyp26c1 in embryogenesis,
we generated Cyp26c1 knockout mice (Supplementary Fig.
1). However, these animals did not manifest overt anatomic
abnormalities (Fig. 1B, data not shown). Although CYP26C1
was previously suggested to restrict the anterior border of the
RA signal in the CNS to the boundary between r4 and r5 after
E8.0 (Sirbu et al., 2005), this border was intact in the
Cyp26c1 null mutant (Supplementary Fig. 3). Our results thus
indicate that CYP26C1 alone is not required for CNS
development and formation of the anterior border of the RA
signal at r4–r5.
Cyp26c1 is chromosomally linked with Cyp26a1, and the
two genes are expressed in overlapping domains (Tahayato et
al., 2003). The lack of apparent defects in Cyp26c1 knockout
mice might therefore be due to functional redundancy
between Cyp26c1 and Cyp26a1. Consistent with this notion,
Cyp26a1 expression is maintained within the normal range
in Cyp26c1−/− embryos (Supplementary Fig. 4A). Most
Cyp26a1 null embryos show a mild hindbrain anomaly, in
contrast to the marked abnormalities of RA-treated animals
(Fig. 1B) (Maden, 2002), suggesting that the effects of
exogenous RA are nonphysiological or that CYP26C1 may
play a role in CNS patterning in cooperation with CYP26A1.
To examine the functional relation between these two
enzymes, we examined the expression patterns of both
genes in wild-type (WT) embryos from the headfold to
two-somite stages (Fig. 1A). The two genes showed similar
expression patterns at each stage, although some differences
were observed (Sirbu et al., 2005). The expression of both
genes begins in the mesenchyme of the anterior region at the
headfold stage, although the expression level of Cyp26a1 is
higher than that of Cyp26c1. Whereas expression of Cyp26a1
in the neuroectoderm also begins at E7.5, that of Cyp26c1
does not begin in the neuroectoderm (r4) until the one-somite
stage (Fig. 1A).
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phenocopy RA embryopathy
To explore whether the apparently normal development of
Cyp26c1−/− mice is attributable to functional compensation by
Cyp26a1, we next generated Cyp26a1−/−Cyp26c1−/−
(Cyp26a1/c1−/−) mice (Supplementary Fig. 2). In contrast to
Cyp26a1−/− or Cyp26c1−/− mice, no viable Cyp26a1/c1−/−
embryos were recovered at E11.0 and all double-mutant
embryos were absorbed by E12.5 (Supplementary Table 1).
At E9.5, Cyp26a1/c1−/− embryos exhibited pronounced CNS
abnormalities including a marked reduction in head size, a
reduced eye and frontonasal region, and failure of neural tube
closure between the forebrain and hindbrain (Fig. 1B). In
addition, the first and second branchial arches of the double-
mutant embryos appeared hypoplastic. The phenotype of
Cyp26a1/c1−/− mice thus appears similar to that of embryos
treated with a teratogenic dose of RA (Fig. 1B). Such a
phenotype was also observed in a small proportion of
Cyp26a1−/− mice (see below). The tailbud, in which only
Cyp26a1 is expressed, showed defects in Cyp26a1/c1−/−
embryos similar to those detected in Cyp26a1−/− mice (data
not shown) (Sakai et al., 2001). These observations were thus
indicative of functional redundancy between Cyp26a1 and
Cyp26c1. Given the apparent lack of CNS anomalies in
Cyp26c1−/− embryos, they also suggest that CYP26C1 function
in the CNS is completely redundant relative to that of
CYP26A1, which appears to play the dominant role.
A–P patterning defects in the CNS of Cyp26a1/c1−/− mice
To determine the mechanistic basis of the CNS malforma-
tions observed in Cyp26a1/c1−/− mice, we first examined the
expression of various genes that mark specific segments along
the A–P neural axis (Fig. 2A, Supplementary Fig. 4), including
Otx2 (entire forebrain to upper midbrain), Hoxb1 (r4), BF1
(ventral telencephalon), Fgf8 (anterior neural ridge and
midbrain–hindbrain junction), En1 (midbrain to midbrain–
hindbrain junction), Meis2 (midbrain and r2–r3), Cyp26b1
(predominantly r5 and r6 at E9.5), and Emx2 (diencephalon).
Although most of these markers were expressed in the
appropriate A–P order in Cyp26a1/c1−/− embryos at E9.5, the
expression domain of Hoxb1 was markedly expanded anteriorly
(Supplementary Fig. 4C). Conversely, the expression domains
of Otx2 and Meis2 in the midbrain were reduced in size in
Cyp26a1/c1−/− embryos (Supplementary Figs. 4C, D), indica-
tive of expansion of the hindbrain at the expense of the forebrain
and midbrain.
Molecular patterning defects in the CNS of Cyp26a1/c1−/−
embryos were already apparent at E8.5 (Figs. 2A, B). The pre-
otic sulcus and otic sulcus in the hindbrain region were thus
absent from Cyp26a1/c1−/− embryos. The expression domain of
Hoxb1was markedly expanded anteriorly, whereas the level and
region ofOtx2 expression were greatly reduced. Consistent with
these observations, the expression domain of Fgf8 was shifted
anteriorly and that of Krox20, which marks r3 and r5, was
observed in a single broad region in the double mutant,suggesting that the hindbrain was not only expanded but also
abnormally patterned. These expression patterns suggest that
specification of r1, r2, and r3 is impaired in Cyp26a1/c1−/−
embryos. The distribution of the RA signal, as revealed by
expression of the RARE-hsplacZ transgene, was also extended
toward the anterior side in the double-mutant embryos (Figs.
2A, B; Supplementary Fig. 3). The patterning defects of the
Cyp26a1/c1−/− CNS were apparent even as early as E7.5
(Supplementary Fig. 5), when Cyp26a1 and Cyp26c1 expres-
sion begins in the anterior head mesenchyme of WT embryos
(Fig. 1A). The boundary between Otx2 and Hoxb1 expression
domains as well as the anterior border of the RARE-hsplacZ
expression domain was thus shifted anteriorly in Cyp26a1/c1−/−
embryos at E7.5.
Cyp26a1−/− mice manifest various defects including tailbud
truncation (Abu-Abed et al., 2001; Sakai et al., 2001). However,
reexamination of Cyp26a1−/− embryos revealed that some of
them showed CNS malformations similar to those of the double
mutant. At E9.5, 20% (3/15) of Cyp26a1−/− embryos exhibited
an open neural tube resembling that in Cyp26a1/c1−/− embryos,
whereas 33% (5/15) and 47% (7/15) of Cyp26a1−/− embryos
manifested less pronounced or no obvious CNS defects,
respectively (Fig. 1B). At E8.5, the extent of theOtx2 expression
domain was reduced in 29% (2/7) and normal in the remaining
71% (5/7) of Cyp26a1−/− embryos (Fig. 2A). Such phenotypic
variation may depend on the level of Cyp26c1 expression in
individual Cyp26a1−/− embryos; indeed, Cyp26c1 expression
was found to be greatly reduced in some Cyp26a1−/− embryos
(M.U. et al., unpublished data). Thus, reevaluation of the
Cyp26a1 null mutant revealed incompletely penetrant defects
suggestive of an important role for CYP26A1 in regulation of
the RA signal during CNS patterning. Together, our results thus
indicated that both CYP26A1 and CYP26C1 contribute to CNS
patterning and, again, that CYP26A1 plays the dominant role.
An increased level of RA is responsible for the CNS defects of
Cyp26a1/c1−/− embryos
To determine whether the CNS defects of Cyp26a1/c1−/−
embryos are attributable to an increased level of RA, we
administered a dose of all-trans-RA sufficient to induce
malformation of the embryonic CNS (8 mg/kg of body mass)
to WT pregnant mice. Administration of RA at both E7.5 and
E8.5 induced CNS anomalies in the WT embryos similar to
those observed in Cyp26a1/c1−/− embryos, including an open
neural tube and underdevelopment of the forebrain and
midbrain (Fig. 1B). Furthermore, a single administration of
RA at E7.5 induced molecular patterning defects similar to
those observed in the Cyp26a1/c1−/− CNS. Expression of Otx2
was thus reduced, whereas the expression domain of Hoxb1
was extended toward the anterior end (Fig. 2C). Conversely, we
examined whether a lack of RALDH2 would rescue the CNS
abnormalities of Cyp26a1/c1−/− embryos. Although Raldh2−/−
mice exhibit various defects themselves, especially on the
caudal side, the rostral CNS appears relatively normal in these
animals (Niederreither et al., 1999) (Fig. 3A). The CNS defects
apparent in Cyp26a1/c1−/− embryos were not observed in
Fig. 2. A–P patterning defects in the CNS of Cyp26a1/c1−/− embryos. (A) Expression of Otx2, Hoxb1, Krox20, Fgf8, and RARE-hsplacZ (red arrowheads) in the CNS
of WT, Cyp26a1/c1−/−, Cyp26a1−/−, and Cyp26c1−/− embryos at E8.5 as revealed by whole-mount in situ hybridization or X-gal staining. The expression domains of
Hoxb1 and RARE-hsplacZwere expanded markedly toward the anterior end, whereas that of Otx2 was greatly reduced, in the double mutant as well as in a minority of
Cyp26a1−/− embryos. Black and white arrowheads indicate the pre-otic sulcus and otic sulcus, respectively. (B) Schematic representation of the expression domains of
the indicated genes in WT and double-mutant embryos at E8.5. fb, forebrain; mb, midbrain; mhb, midbrain–hindbrain boundary; r1 to r6, rhombomeres 1 to 6. (C)
Induction by exogenous RA of A–P patterning defects (arrowheads) in the CNS of WT embryos similar to those of Cyp26a1/c1−/− embryos. All-trans-RA was
administered to pregnant WT mice at E7.5; embryos were recovered 24 h later and subjected to whole-mount in situ hybridization.
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molecular patterning defects of the Cyp26a1/c1−/− CNS were
rescued by ablation of Raldh2 (Fig. 3B). These results suggest
that an increased level of RA is responsible for malformation of
the forebrain and midbrain in Cyp26a1/c1−/− embryos.
Paucity of head mesenchyme cells in Cyp26a1/c1−/− embryos
Histological analysis revealed that the number of cells in
the head mesenchyme was greatly reduced in Cyp26a1/c1−/−Fig. 3. Rescue of the CNS defects of Cyp26a1/c1−/− embryos by ablation of Raldh2.
c1−/−, and Cyp26a1/c1−/−Raldh2−/− embryos at E9.25. The rostral CNS malform
Cyp26a1/c1−/−Raldh2−/− embryos. h, heart. (B) Expression of Otx2 and Hoxb1 in the
at E8.75 or E8.5. The molecular patterning defects (arrowheads) observed in Cyp26
Hematoxylin–eosin staining of WT, Raldh2−/−, Cyp26a1/c1−/−, and Cyp26a1/c1−/−R
embryos are shown, one with mild (left) and the other with severe (right) CNS defects
in Cyp26a1/c1−/− embryos but was almost normal in Cyp26a1/c1−/−Raldh2−/− em
horizontal lines through the embryos in the upper panels. Asterisks indicate the regiembryos at E8.75 compared with that in WT embryos (Fig.
3C). This reduction was apparent in the forebrain, midbrain,
and anterior portion of the hindbrain but not in the remaining
more caudal regions of the CNS (Supplementary Fig. 6).
Neither a reduced extent of cell proliferation nor an increased
rate of apoptosis appeared to be responsible for the impaired
formation of the head mesenchyme in Cyp26a1/c1−/−
embryos, given that immunohistochemical analysis did not
reveal abnormal staining either for phosphorylated histone H3
(marker for proliferating cells) or for the active form of(A) Lateral (main panels) and dorsal (insets) views of WT, Raldh2−/−, Cyp26a1/
ations (arrowheads) apparent in Cyp26a1/c1−/− embryos were not evident in
CNS of WT, Raldh2−/−, Cyp26a1/c1−/−, and Cyp26a1/c1−/−Raldh2−/− embryos
a1/c1−/− embryos were not apparent in Cyp26a1/c1−/−Raldh2−/− embryos. (C)
aldh2−/− embryos at E8.75 (11-somite stage). Two representative Cyp26a1/c1−/−
. The number of cells in the head mesenchyme (arrowheads) was greatly reduced
bryos. The planes of sections shown in the lower panels are indicated by the
ons positive for EMT. Scale bars, 100 μm.
Fig. 4. Intact NCC induction and impaired NCC delamination in Cyp26a1/c1−/−
embryos. (A) Expression of Snail and Sox9 in the CNS of WT, Cyp26a1/c1−/−,
and RA-treated WT embryos at E8.5 (six-somite stage). For each type of
embryo, lateral and dorsal views are shown on the left, and frontal sections at the
level of the midbrain indicated by the vertical line in the lateral view are shown
on the right. In WT embryos, expression of Snail and Sox9 was detected at the
edges of the neural plate (asterisks) in premigratory NCCs and that of Snail was
also apparent in migratory NCCs. In Cyp26a1/c1−/− and RA-treated embryos,
however, Snail and Sox9 expression was maintained in the neural plate, but the
delamination of NCCs was markedly inhibited (asterisks). The edge of the
neural plate was also thickened (asterisks) in Cyp26a1/c1−/− embryos. A close
relation between the neuroectoderm and head mesenchyme, representing the
delamination of NCCs, was apparent in the WT but not in the double mutant.
Snail-expressing cells in the head mesenchyme of Cyp26a1/c1−/− embryos
were likely derived from the presumptive r4 (see text). fd, foregut diverticulum;
h, heart. Scale bars, 100 μm. (B, C) Higher magnification images of the boxed
regions in panel A. The outlined areas indicate Snail-expressing mesenchyme.
Scale bars, 50 μm.
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midbrain regions of the double mutant at a time immediately
before that corresponding to the beginning of NCC migration
in the WT (Supplementary Fig. 7A). Consistent with these
findings, the number of neuroectoderm cells in Cyp26a1/c1−/−
embryos at E8.5 was similar to that in the WT (Supplementary
Fig. 8).
Head mesenchyme cells originate from both NCCs and
mesoderm (Noden, 1988). Mesenchyme cells were detected in
the CNS of Cyp26a1/c1−/− embryos at E8.0 (Supplementary
Fig. 7B), before the onset of migratory NCC production,
suggesting that mesoderm-derived mesenchyme is formed
normally and that mesenchyme derived from NCCs is deficient
in the double-mutant embryos. Although the production of
migratory NCCs was impaired in the entire region between the
forebrain and r4 in Cyp26a1/c1−/− embryos at E8.5, a small
number of head mesenchyme cells was detected in the
presumptive midbrain at E9.25 (Supplementary Fig. 7D) (see
below).
Production of migratory cranial NCCs is impaired in
Cyp26a1/c1−/− embryos
To confirm further the impairment of migratory cranial NCC
production in Cyp26a1/c1−/− embryos, we examined the
expression of genes that are expressed specifically in NCCs.
In WT embryos at E8.5, NCC-specific markers such as Snail,
Sox9, and AP2 are expressed in NCCs that emigrate from the
forebrain, midbrain, r2, and r4 regions (Fig. 4A, Supplementary
Fig. 9); Sox9 marks premigratory NCCs whereas Snail is also
expressed in migrating and delaminating NCCs (Figs. 4A, B).
Although expression of Snail, Sox9, and AP2 was maintained
in the neural plate of the forebrain and midbrain regions of
Cyp26a1/c1−/− embryos, most of the cells expressing Snail
remained within the neural plate (Figs. 4A, C). These results
suggest that premigratory NCCs are formed normally in
Cyp26a1/c1−/− embryos, and that it is the cells derived from
NCCs that are lost in the head mesenchyme of the forebrain and
midbrain. Intact Wnt1 expression of the midbrain in double-
mutant mice also reinforces this notion (Supplementary Fig. 9).
Given that migratory cranial NCCs are formed by the
epithelial–mesenchymal transition (EMT), the loss of head
mesenchyme cells in Cyp26a1/c1−/− embryos is likely due to
impairment of the EMT of NCCs. The close relation apparent
between migratory cranial NCCs and the neuroectoderm–
ectoderm junction in WT embryos was not observed in
Cyp26a1/c1−/− embryos by histological analysis, which is
also suggestive of a severe impairment of the EMT. A similar
defect in migratory NCC production, albeit less severe, was
observed in RA-treated WT embryos (Fig. 4A). Furthermore,
the neuroectoderm–ectoderm junction in Cyp26a1/c1−/−
embryos was thickened, suggesting that cranial NCCs that
failed to undergo the EMT accumulated in the neural plate. To
characterize further the EMTof cranial NCCs, we examined the
expression of E-cadherin, which is down-regulated during the
EMT in WT embryos (Cano et al., 2000) (Fig. 5A). Expression
of E-cadherin was not down-regulated in the region of theCyp26a1/c1−/− neural plate in which premigratory NCCs reside
(Fig. 5A). Down-regulation of N-cadherin (Nakagawa and
Takeichi, 1998) occurred normally in the Cyp26a1/c1−/−
embryos (Fig. 5A). The sustained production of E-cadherin in
Cyp26a1/c1−/− embryos thus also supports the notion that
cranial NCCs fail to undergo the EMT, although N-cadherin is
down-regulated normally.
Examination of a series of frontal sections indicated that
the production of migratory NCCs was impaired in the entire
region between the forebrain and r4, but was normal in more
caudal regions, of Cyp26a1/c1−/− embryos (Supplementary
Fig. 6). Consistent with this conclusion, the trigeminal (V)
Fig. 5. Cranial NCCs of Cyp26a1/c1−/− embryos fail to undergo the EMT. (A) Immunofluorescence staining for E-cadherin and N-cadherin in frontal sections at the
level of the midbrain of WT and Cyp26a1/c1−/− embryos at E8.5 (eight-somite stage). Expression of E-cadherin in the neural plate had undergone down-regulation in
the WT embryo but not in the mutant embryo. Expression of N-cadherin in the neural plate did not differ between the two genotypes. Blue fluorescence represents
nuclear staining with 4,6-diamidino-2-phenylindole. Asterisks indicate the region positive for EMT, and the circled region contains delaminating NCCs. np, neural
plate; e, ectoderm. Scale bars, 100 μm. (B) Cranial ganglia of WT and Cyp26a1/c1−/− embryos at E9.5. Nerves were visualized by neurofilament staining. The
trigeminal (V) ganglia, which are derived from NCCs of r2, were missing, r4-derived cranial (VII, VIII) ganglia were hypoplastic, and r6-derived cranial (IX, X)
ganglia were normal in Cyp26a1/c1−/− embryos. b1, first branchial arch; ov, otic vesicle; h, heart.
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Cyp26a1/c1−/− embryos (Fig. 5B). The r4-derived cranial
(VII, VIII) ganglia were hypoplastic, although the molecular
identity of r4 (Hoxb1) was not affected, and the r6-derived
cranial (IX, X) ganglia were formed normally in the double-
mutant embryos. These results suggest that the production of
migratory cranial NCCs is inhibited in the region between the
forebrain and r4. This conclusion was confirmed by monitor-
ing the fate of the NCC lineage (see below).
We next examined whether a lack of RALDH2 would
rescue the failure of migratory NCC production in Cyp26a1/
c1−/− embryos. Histological analysis revealed that, in three of
six Cyp26a1/c1−/−Raldh2−/− embryos at E8.75, the number of
cells in the head mesenchyme was similar to that of WT
embryos (Fig. 3C, data not shown), indicating that the
migratory NCC production defect of Cyp26a1/c1−/− embryos
is indeed rescued by ablation of Raldh2. The observed
phenotypic variation may depend on the level of maternal
RA in individual Cyp26a1/c1−/−Raldh2−/− embryos. An
increased level of RA thus appears to be responsible for the
defect in migratory cranial NCC production in Cyp26a1/c1−/−
embryos.Fates of cranial premigratory NCCs in Cyp26a1/c1−/−
embryos
To examine the fates of premigratory NCCs in Cyp26a1/
c1−/− embryos, we labeled these cells in r4 and the midbrain
with the fluorescent dye DiI. DiI labeling was performed at the
zero- to two-somite stage, before the migration of cranial
NCCs begins (Fig. 6A). In WT embryos, the labeled cells in
the presumptive r4 region contributed to the second branchial
arch whereas those in the presumptive midbrain contributed to
the frontonasal region and the first branchial arch (Fig. 6B).
These migration patterns are consistent with those observed
previously (Osumi-Yamashita et al., 1994). In Cyp26a1/c1−/−
embryos, however, NCC migration was markedly impaired.
NCCs in the presumptive r4 region migrated toward the second
branchial arch but did so more broadly (Fig. 6B). The
production of migratory NCCs was thus not completely
blocked in the r4 region of the double-mutant embryos.
However, the number of migratory NCCs derived from r4 in
Cyp26a1/c1−/− embryos was smaller than that apparent in
WT embryos, consistent with the observations that the second
branchial arch (Fig. 1B) and the facial ganglia (Fig. 5B) are
Fig. 6. Fates of cranial premigratory NCCs in Cyp26a1/c1−/− embryos. (A) WT embryos injected with DiI (red fluorescence) in the presumptive r4 and midbrain (mb)
regions at E8.0. Arrowheads indicate injection sites. (B) WT and Cyp26a1/c1−/− embryos injected as in panel A were cultured for 24 h and then examined for the
distribution of DiI-labeled cells. Labeled cells that emigrated from the presumptive r4 region were detected in the second branchial arch (b2) of WT embryos but
contributed to the anterior region of the mutant embryos. Whereas labeled cells migrated from the presumptive midbrain to the frontonasal (fn) region and the first
branchial arch (b1) of WT embryos, they failed to do so in the mutant embryos. Left and right panels in each instance are bright-field and dark-field images,
respectively. ov, otic vesicle; h, heart.
407M. Uehara et al. / Developmental Biology 302 (2007) 399–411hypoplastic in Cyp26a1/c1−/− embryos. This small population
of detectable migratory NCCs is also consistent with the
presence of Snail-expressing cells in head mesenchymal
tissue of the double mutant at E8.5 (Figs. 4A, C). Similar
migration defects were previously observed with RA-treated
rat embryos (Lee et al., 1995). Migration of the midbrain
NCCs was impaired to an even greater extent in Cyp26a1/
c1−/− embryos (Fig. 6B). The number of migrating cells was
thus greatly reduced, and the labeled cells failed to migrate
toward the first branchial arch (or the frontonasal region).
Impaired migration of midbrain NCCs is consistent with the
observation that the first branchial arch is hypoplastic in
Cyp26a1/c1−/− embryos (Fig. 1B). However, a small number
of cells did migrate anteriorly over a short distance in the
mutant embryos (Fig. 6B), possibly explaining the presence
of a small number of head mesenchyme cells derived from
the midbrain at E9.25 (Supplementary Fig. 7D). Finally, cells
positive for the active form of caspase-3 were specifically
detected among the premigratory NCCs of Cyp26a1/c1−/−
embryos at E8.75 (Supplementary Fig. 7C), a stage at which
NCC migration has begun in WT embryos, suggesting that
NCCs that fail to undergo the EMT are subsequently removed
by apoptosis.Discussion
The role of CYP26C1 in CNS patterning is dependent on
cooperation with CYP26A1
It is unknown whether or not the three CYP26 enzymes
identified in mammals have identical enzymatic activities in
vivo. Biochemical data suggest that the activity of CYP26C1
manifests only slight differences relative to the activities of
CYP26A1 and CYP26B1 (Taimi et al., 2004). In spite of such
redundancy in activity and the overall similarity in expression
patterns between CYP26C1 and CYP26A1, CYP26C1 has been
thought to play a role distinct from that of CYP26A1 because of
its different expression pattern in the hindbrain (Sirbu et al.,
2005). The onset of Cyp26c1 expression in r4 at E8.0 coincides
with the caudal shift of the anterior boundary of the RA signal
from r2–r3 to r4–r5, whereas Cyp26a1 expression is not clearly
restricted to pro-rhombomere structures at this stage (Fig. 1A).
However, we have now shown that mice that lack CYP26C1
develop without overt abnormalities. The anterior boundary of
the RA signal at r4–r5 thus forms correctly and the CNS
develops normally in the Cyp26c1−/− embryos. In contrast,
compared with Cyp26a1−/− mice, Cyp26a1/c1−/− mice exhibit
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and Cyp26c1 are coexpressed. These genetic data indicate that
CYP26C1 plays a role in CNS patterning in cooperation with
CYP26A1. The role of CYP26B1 in determination of the RA
signal boundary at r4–r5 remains unclear. The expression of
Cyp26c1 begins at r4 earlier than does that of Cyp26b1 at r3
and r5 (MacLean et al., 2001; Sirbu et al., 2005), and the
Cyp26b1−/− mutant does not exhibit a hindbrain patterning
defect (Yashiro et al., 2004). Ectopic Cyp26b1 expression was
not detected in Cyp26c1−/− embryos (data not shown), but it
remains possible that the unchanged boundary of the RA signal
at r4–r5 in Cyp26c1−/− mice may be due to redundancy not
only with CYP26A1 but with CYP26B1.
Regulation of RA distribution along the A–P axis in the CNS
Although exogenous RA exhibits profound pharmacological
effects on CNS development (Maden, 2002), the physiological
mechanism by which the RA signal synthesized by the embryo
itself is controlled appropriately in the CNS has remained
unclear. Our data now reveal an essential function of CYP26
enzymes in brain patterning. The correct specification of the
forebrain and midbrain requires that the corresponding
precursor regions of the developing embryo be maintained
devoid of RA through the action of a “CYP26A1-CYP26C1
cassette” in the anterior portion of the CNS. RA thus acts as an
anti-anteriorizing factor. It has been suggested that administra-
tion of exogenous RA to the chick embryo induces forebrain
truncation through down-regulation of Fgf8 expression in the
anterior neural ridge (Creuzet et al., 2004; Schneider et al.,
2001). In Cyp26a1/c1−/− mice, however, the forebrain is
reduced in size but Fgf8 expression is maintained in the
anterior neural ridge. This discrepancy may be due to a
difference in the response to RA between chick and mouse
embryos. Alternatively, RA synthesized de novo in the body
trunk might not diffuse as far as the anterior end of the CNS,
given that the most anterior portion of Cyp26a1/c1−/− embryos
at E7.5 and E8.5 was negative for RARE-hsplacZ expression
(Fig. 2A, Supplementary Fig. 5). We did not detect ectopic
Cyp26b1 expression in Cyp26a1/c1−/− embryos, suggesting
that CYP26B1 does not serve as a diffusion barrier in these
embryos.
The hindbrain of Cyp26a1/c1−/− embryos is also abnormally
patterned. Anterior expansion of the Hoxb1 expression domain
up to near the midbrain–hindbrain boundary suggests that r1 to
r3 may be misspecified to r4 identity. The lack of Meis2
expression in this region of Cyp26a1/c1−/− embryos is
consistent with this notion (Supplementary Fig. 4D). The
observations that the trigeminal ganglia were almost completely
ablated and that the first branchial arch was severely hypoplastic
in Cyp26a1/c1−/− embryos are also consistent with this
conclusion, although these abnormalities might also be
explained by the EMT defect. The analysis of cell lineage
with DiI revealed migration of NCCs derived from r4 to
inappropriate anterior sites in the double mutant, suggesting that
these cells had a mixed-lineage identity of r1 to r4. Such
patterning defects in the hindbrain of Cyp26a1/c1−/− embryosare more severe than those previously described for Cyp26a1−/−
embryos, in which only r3 adopts r4 identity (Sakai et al., 2001).
Cyp26a1 and Cyp26c1 show dynamic expression in various
domains of the mouse embryo (Fig. 1A) (Fujii et al., 1997;
Tahayato et al., 2003). The expression of Cyp26a1 and
Cyp26c1 begins simultaneously at the headfold stage, that of
Cyp26a1 in both the neuroectoderm and head mesenchyme
and that of Cyp26c1 only in head mesenchyme. Previous
observations suggested that CYP26A1 first establishes the
anterior boundary of the RA signal at r2–r3 and that CYP26C1
in the neuroectoderm (r4) subsequently shifts this boundary to
r4–r5 (Sirbu et al., 2005). However, our results now show that
this latter boundary was not disrupted in Cyp26c1−/− embryos
and that most Cyp26a1−/− embryos manifest normal hindbrain
patterning. We therefore propose a modified model for
regulation of the distribution of the RA signal (Fig. 7). First,
CYP26A1 and CYP26C1 in the mesenchyme prevent the
delivery of RA to the neuroectoderm through head mesench-
ymal tissue at the headfold stage. The delivery of RA to the
rostral CNS region via neuroectoderm is thus restricted. The
posterior border of CYP26A1 expression is located more
anteriorly in neuroectoderm than in mesenchyme, resulting in a
graded distribution of RA in the presumptive hindbrain region
that might be responsible for induction of the r2–r3 boundary
and r4 identity (Sirbu et al., 2005). The induction of r4 identity
through this process may establish Cyp26c1 expression in r4. It
appears that CYP26 initially acts in a non-cell-autonomous
manner, given that most Cyp26a1−/− embryos show normal or
nearly normal CNS development and that the lack of CYP26C1
in the mesenchyme affects the adjacent neuroectoderm in
Cyp26a1/c1−/− embryos. Given that molecular patterning
defects are apparent as early as E7.5 in all Cyp26a1/c1−/−
embryos, the lack of CYP26 expression not only in the anterior
head mesenchyme but also in neuroectoderm at the headfold
stage is likely primarily responsible for the impaired A–P
patterning of Cyp26a1/c1−/− embryos. At the one-somite stage,
when Cyp26c1 is expressed at a high level in r4 of WTembryos,
caudal repression of Hoxb1 expression was apparent in
Cyp26a1/c1−/− embryos, although the formation of a sharp
border at r4–r5 seems slightly disrupted. These results also
support the notion that expression of vHnf1 is sufficient for
caudal repression of Hoxb1 (Sirbu et al., 2005).
RA regulates the production of migratory cranial NCCs
Several lines of evidence suggest that the paucity of head
mesenchyme cells in Cyp26a1/c1−/− embryos results from an
EMT defect of cranial NCCs: (1) The extents of cell proliferation
and apoptosis were not affected in Cyp26a1/c1−/− embryos at
E8.5 (four- to five-somite stage), when NCC delamination has
already begun in WT embryos. (2) The histological features of
the EMT observed in the midbrain region of WT embryos,
including the close relation between head mesenchyme and
neuroectoderm, were not apparent in the Cyp26a1/c1−/−mutant.
(3) NCC induction appeared to be intact in the double mutant, as
revealed by the expression patterns of Wnt1, Sox9, AP2, and
Snail within the neuroectoderm, but the NCCs seemed to
Fig. 7. Model for RA signal regulation along the A–P axis of the early mouse CNS by CYP26 enzymes. The top panel represents the expression domains of Cyp26a1,
Cyp26c1, and Raldh2 as well as the distribution of the RA signal at E7.5, when Cyp26b1 expression has not yet begun. Arrows indicate the route of RA delivery. The
middle panel shows the putative distribution of RA in neuroectoderm and head mesenchyme (mesoderm). The expression domains of Cyp26a1 and distribution of the
RA signal at E7.5 are shown in the lower panels. AWTembryo harboring the RARE-hsplacZ transgene was subjected to Rose-gal staining and then to whole-mount in
situ hybridization with a Cyp26a1 probe at E7.5. Cryosections were then prepared and examined. Blue arrowheads, posterior boundary of Cyp26a1 expression; red
arrowheads, anterior boundary of the RA signal.
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neuroectoderm and ectoderm. (4) E-cadherin expression was
maintained at the junction between the ectoderm and
neuroectoderm in Cyp26a1/c1−/− embryos. (5) Lineage tracing
of NCCs with DiI revealed few migratory cranial NCCs
derived from the midbrain region. And (6) E-cadherin
induction by RA was previously shown to trigger epithelial
differentiation of a breast cancer cell line (Shah et al., 2002). It
remains possible that NCCs are lost by apoptosis immediately
before the EMT in Cyp26a1/c1−/− embryos. However, this is
not likely given that apoptotic cells were not detected in these
embryos at the four-somite stage, when NCC delamination has
already begun in WT embryos. Another possible explanation
for the paucity of head mesenchyme cells in the double-mutant
embryos is suggested by the observation that many
Cyp26a1/c1−/− embryos manifested a thin neuroectoderm,
indicative of a reduction in total cell number including that of
NCC precursors. Whereas the extents of cell proliferation and
cell death appeared similar in WT and Cyp26a1/c1−/− embryos,
it remains possible that some mutant embryos are defective in
these processes. Further studies are thus required to assess
whether RA inhibits the EMT of cranial NCCs.
Cadherins such as E-cadherin and N-cadherin are down-
regulated in delaminated NCCs of WT embryos (Cano et al.,
2000; Nakagawa and Takeichi, 1998; Weston et al., 2004;
Zhadanov et al., 1999), but E-cadherin was not down-
regulated in the region of Cyp26a1/c1−/− embryos in which
premigratory NCCs reside. This latter finding suggests that the
EMT defect in Cyp26a1/c1−/− embryos is primarily respon-
sible for the paucity of head mesenchyme, given that down-
regulation of cadherins is required for delamination and
migration of NCCs (Cano et al., 2000; Nakagawa andTakeichi, 1998). It has been suggested that Snail mediates
down-regulation of expression of the E-cadherin gene (Cano et
al., 2000). On the other hand, RA is able to up-regulate E-
cadherin expression indirectly (Shah et al., 2002). In Cyp26a1/
c1−/− embryos, however, E-cadherin failed to undergo down-
regulation even in the presence of Snail expression, suggesting
that down-regulation of E-cadherin is not directly controlled
by Snail in vivo, or that E-cadherin expression is regulated by
RA and Snail independently. A mechanism for regulation of E-
cadherin expression independently of Snail was recently
suggested (Zohn et al., 2006). The failure of migratory NCC
production was apparent specifically in the region of
Cyp26a1/c1−/− embryos between the forebrain and r4. In
addition, this defect was more severe in more anterior regions.
NCCs in the trunk of the mutant embryos gave rise to
migratory NCCs normally even though they were exposed to
the RA signal. These observations suggest that cranial NCCs,
especially those within the midbrain, are sensitive to RA
whereas NCCs of the body trunk are resistant to it.
Furthermore, the relatively late onset of apoptosis in
premigratory NCCs of double-mutant embryos suggests that
apoptosis is secondary to failure of migratory cranial NCC
production.
How is the defect of migratory cranial NCC production in
Cyp26a1/c1−/− embryos related to the A–P patterning defects?
It is possible that the production defect is directly induced by
inappropriate RA signaling as a result of the lack of CYP26a1
and CYP26c1 expression beginning at E7.5. The severe
production defect was restricted to the forebrain and midbrain,
the same regions that showed A–P patterning defects at both
morphological and molecular levels, suggestive of a close
relation between A–P axis identity and the production of
410 M. Uehara et al. / Developmental Biology 302 (2007) 399–411migratory NCCs. Alternatively, the two types of defects may be
independent, given that similar migratory NCC production
defects have not been observed in other mouse mutants, such as
Otx2 knockout mice, that exhibit abnormal A–P patterning
(Martinez-Barbera et al., 2001). Our results show that, in the
presence of the RA signal, cranial NCCs are formed correctly
but fail to produce migratory NCCs. Elucidation of the precise
mechanism responsible for the failure of migratory cranial NCC
production in Cyp26a1/c1−/− embryos may clarify how the
delamination of NCCs is regulated.
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